Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Other Long-Term Liabilities
$5.46 Mil (As of Sep. 2014)

Synageva BioPharma Corp's other long-term liabilities for the quarter that ended in Sep. 2014 was $5.46 Mil.

Synageva BioPharma Corp's quarterly other long-term liabilities increased from Mar. 2014 ($4.83 Mil) to Jun. 2014 ($5.35 Mil) and increased from Jun. 2014 ($5.35 Mil) to Sep. 2014 ($5.46 Mil).

Synageva BioPharma Corp's annual other long-term liabilities increased from Dec. 2011 ($-0.00 Mil) to Dec. 2012 ($0.00 Mil) and increased from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($3.83 Mil).


Definition

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart’s balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all “Other Long-Term Liabilities”.


Related Terms

Total Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Other Long-Term Liab. 27.6227.6928.2220.3618.3518.670.13-0.000.003.83

Synageva BioPharma Corp Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
Other Long-Term Liab. 0.000.000.000.000.721.573.834.835.355.46
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK